Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Receives $56.00 Consensus Price Target from Analysts
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) has earned a consensus rating of “Buy” from the nine ...
ZEO ScientifiX Provides Business Update to Stockholders and the Investment Community
FORT LAUDERDALE, FL / ACCESSWIRE / February 11, 2025 / ZEO ScientifiX, Inc. ('ZEO' or the 'Company') (OTCQB:ZEOX), a clinical-stage biopharmaceutical company fo ...